No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...
The $21.7-million project is intended to reduce Kamloops' Kruger Pulp mill's dependence on natural gas by 16 per cent.
The mRNA synthesis and manufacturing market's potential lies in the increasing demand for mRNA therapeutics and vaccines, driven by COVID-19 successes. Opportunities include mRNA custom synthesis and ...
We came across a bullish thesis on Novavax, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...
KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
We came across a bullish thesis on CureVac N.V. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, and ...
Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...
RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback